The European project FLAMIN-GO is underway: within the potential of precision medicine, a breakthrough for the treatment of rheumatoid arthritis
The FLAMIN-GO research project, designed to develop "tailored" treatments for each patient suffering from Rheumatoid Arthritis, has now begun. Under the leadership of the University of Eastern Piedmont, the project originated from a collaboration among different public and private organizations, including the Institute of Nanotechnology of the National Research Council (Cnr Nanotec) at Lecce, Queen Mary University of London, the Max Planck Institute, and the Swiss AO Foundation.
Press release CNR.
Nuovo Quotidiano di Puglia of 05/02/2021 - pag. 11.
LSWN - Le Scienze Web News.
RAI - TgR Leonardo of 12/02/2021.